VJHemOnc Podcast cover image

Sequencing therapies in R/R NHL: immunotherapy in DLBCL, BTKis in MCL, & more!

VJHemOnc Podcast

00:00

Innovations in Mantle Cell Lymphoma Treatment

This chapter examines the changing treatment landscape for relapsed refractory mantle cell lymphoma, emphasizing the role of TP53 mutations in guiding therapy decisions. It discusses the shift from traditional treatments to novel BTK inhibitors and CAR T-cell therapies, along with the implications of bispecific antibodies as potential alternatives. The speakers also cover challenges related to accessibility and reimbursement, highlighting the need for real-world data to inform treatment choices.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app